翔宇医疗11月21日获融资买入497.13万元，融资余额1.60亿元

Group 1 - The core viewpoint of the news is that Xiangyu Medical experienced a decline in stock price and trading volume on November 21, with a drop of 3.92% and a transaction amount of 60.05 million yuan [1] - On November 21, the financing buy-in amount for Xiangyu Medical was 4.97 million yuan, while the financing repayment was 6.06 million yuan, resulting in a net financing buy-in of -1.09 million yuan [1] - As of November 21, the total balance of margin trading for Xiangyu Medical was 160 million yuan, which accounts for 2.24% of its circulating market value, indicating a high level compared to the past year [1] Group 2 - As of September 30, the number of shareholders for Xiangyu Medical was 9,531, an increase of 51.24% compared to the previous period, while the average circulating shares per person decreased by 33.88% to 16,787 shares [2] - For the period from January to September 2025, Xiangyu Medical achieved an operating income of 537 million yuan, representing a year-on-year growth of 6.00%, but the net profit attributable to the parent company was 43.98 million yuan, a decrease of 40.09% year-on-year [2] - Since its A-share listing, Xiangyu Medical has distributed a total of 277 million yuan in dividends, with 157 million yuan distributed in the last three years [3]